Panagora Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-11,245
| Closed | -$54K | – | 2824 |
|
2019
Q2 | $54K | Sell |
11,245
-626
| -5% | -$3.01K | ﹤0.01% | 2078 |
|
2019
Q1 | $65K | Hold |
11,871
| – | – | ﹤0.01% | 1989 |
|
2018
Q4 | $36K | Buy |
+11,871
| New | +$36K | ﹤0.01% | 2062 |
|
2016
Q2 | – | Sell |
-1,649
| Closed | -$109K | – | 2394 |
|
2016
Q1 | $109K | Buy |
1,649
+1,278
| +344% | +$84.5K | ﹤0.01% | 1836 |
|
2015
Q4 | $23K | Sell |
371
-1,977
| -84% | -$123K | ﹤0.01% | 2129 |
|
2015
Q3 | $157K | Buy |
2,348
+446
| +23% | +$29.8K | ﹤0.01% | 1680 |
|
2015
Q2 | $185K | Buy |
+1,902
| New | +$185K | ﹤0.01% | 1725 |
|
2014
Q1 | – | Sell |
-486
| Closed | -$20K | – | 2405 |
|
2013
Q4 | $20K | Sell |
486
-143
| -23% | -$5.89K | ﹤0.01% | 2098 |
|
2013
Q3 | $19K | Sell |
629
-519
| -45% | -$15.7K | ﹤0.01% | 2199 |
|
2013
Q2 | $61K | Buy |
+1,148
| New | +$61K | ﹤0.01% | 1973 |
|